Abstract
We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a antibody.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Eye Diseases / drug therapy*
-
Eye Diseases / etiology
-
Female
-
Graves Disease / complications*
-
Humans
-
Infliximab
-
Middle Aged
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antibodies, Monoclonal
-
Tumor Necrosis Factor-alpha
-
Infliximab